NCT02191384 - Comparison of Orcinoside With Placebo in Treatment of MDD | Biotech Hunter

Enrollment

186

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 9, 2016

Study Completion Date

March 9, 2016

Conditions

Major Depressive Disorder (MDD)

Interventions

DRUG

Orcinoside

oral, twice per day

Trial Locations (10)

Peking University Sixth Hospital, Beijing

Shanghai Mental Health Center, Shanghai

Nanjing Brain Hospital, Nanjing

Wuxi Mental Health Center, Wuxi

Wuhan Mental Health Center, Wuhan

Guangzhou Brain Hospital, Guangzhou

First Affiliated Hospital of Kunming Medical University, Kunming

the first affiliated hospital of Xi'an Jiaotong University, Xi'an

Xi'an Mental Health Center, Xi'an

Hebei Province Mental Health Center, Baoding

All Listed Sponsors

collaborator

Kun Ming KingBio Biotechnology Co. LTD

UNKNOWN

lead

Shanghai Mental Health Center

OTHER